Purchase one-time access:Academic and Personal
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Obstetrics and Gynaecology Canada
- Delivery type, opioid prescribing, and the risk of persistent opioid use after delivery.Am J Obstet Gynecol. 2019; 220: 405-407
- Rates of new persistent opioid use after vaginal or caesarean birth among US women.JAMA Network Open. 2019; 2
- Use of a sparse sampling study design to assess transfer of tramadol and its O – desmethyl metabolite into transitional breast milk.Br J Clin Pharmacol. 2008; 65: 661-666
- FDA drug safety communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women.(Available at:)www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-restricts-use-prescription-codeine-pain-and-cough-medicines-and(Accessed December 22, 2021)
- Bias in before–after studies.Anesth Analg. 2018; 126: 1755-1762
- The Alberta pain strategy: achieving excellence in pain management.(Available at:)Accessed December 22, 2021)
- Implementation of a quality improvement initiative to decrease opioid prescribing after cesarean delivery.Obstet Gynecol. 2018; 132: 631
Publication stageIn Press Journal Pre-Proof
Disclosures: The authors declare they have nothing to disclose.
All authors have indicated they meet the journal’s requirements for authorship.